Back
Biotest AG 10K Form
Sell
16
BIESF
Biotest AG
Last Price:
30.48
Seasonality Move:
-4.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIESF News And Ratings
See the #1 stock for the next 7 days that we like better than BIESF
BIESF Financial Statistics
Sales & Book Value
| Annual Sales: | $741.15M |
|---|---|
| Cash Flow: | $-24.66M |
| Price / Cash Flow: | 12.22 |
| Annual Sales: | $14.89 |
| Price / Book: | 2.05 |
Profitability
| EPS (TTM): | 1.83770 |
|---|---|
| Net Income (TTM): | $73.83M |
| Gross Margin: | $303.46M |
| Return on Equity: | 13.32% |
| Return on Assets: | 4.9% |
Biotest AG Earnings Forecast
Key Biotest AG Financial Ratios
- The Gross Profit Margin over the past 22 years for BIESF is 40.94%.
- The Selling, General & Administrative Expenses for BIESF have been equal to 11.83% of Gross Profit Margin.
- The Research & Development expenses have been 9.76% of Revenue.
- The Interest Expense is 31.50% of Operating Income.
- The Net Earning history of BIESF is 18.55% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 12 years.
Biotest AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BIESF |
| Website: | biotest.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.54 |
| Quick Ratio: | 0.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.8 |
|---|---|
| Forward P/E Ratio: | 0 |
BIESF Technical Analysis vs Fundamental Analysis
Sell
16
Biotest AG (BIESF)
is a Sell
Is Biotest AG a Buy or a Sell?
-
Biotest AG stock is rated a Sell
The current Biotest AG [BIESF] share price is $30.48. The Score for BIESF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.